Últimas publicaciones
- Castillo-Ecija H, Monterrubio C, Pascual-Pastó G, Gomez-Gonzalez S, Garcia-Dominguez DJ, Hontecillas-Prieto L, Resa-Pares C, Burgueño V, Paco-Mercader S, Gene-Olaciregui N, Vilà-Ubach M, Restrepo-Perdomo C, Cuadrado-Vilanova M, Balaguer-Lluna L, Pérez-Jaume S, Castañeda-Heredia A, Vicente Santa-María López, Roldan M, Suñol M, de Alava E, Mora J, Lavarino C and Montero-Carcaboso A Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution. JOURNAL OF CONTROLLED RELEASE . 324: 440-449.
- Fernández-Rodríguez J, Morales-La Madrid A, Gel B, Castañeda-Heredia A, Salvador-Hernandez H, Martínez-Iniesta M, Moutinho C, Morata J, Heyn H, Blanco I, Creus-Bachiller E, Capella G, Farré L, Vidal A, Soldado F, Krauel L, Suñol M, Serra E, Villanueva A and Lázaro C Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor. THER ADV MED ONCOL . 12: 1758835920929579.
- Ding YY, Panzer J, Maris JM, Castañeda-Heredia A, Marta Gómez Chiari and Mora J Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma: A case series. PEDIATRIC BLOOD & CANCER . 65(1): .